Each 50 drop serving contains: Vaccinium vitis-idaea 1:200 extract (DHE: 0.25 mg) 0.05 mL. Other Ingredients: Alcohol, Glycerin, Purified Water.
Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
In 2004, Canada began regulating natural medicines as a category of products separate from foods or drugs. These products are officially recognized as "Natural Health Products." These products include vitamins, minerals, herbal preparations, homeopathic products, probiotics, fatty acids, amino acids, and other naturally derived supplements.
In order to be marketed in Canada, natural health products must be licensed. In order to be licensed in Canada, manufacturers must submit applications to Health Canada including information about uses, formulation, dosing, safety, and efficacy.
Products can be licensed based on several criteria. Some products are licensed based on historical or traditional uses. For example, if an herbal product has a history of traditional use, then that product may be acceptable for licensure. In this case, no reliable scientific evidence is required for approval.
For products with non-traditional uses, some level of scientific evidence may be required to support claimed uses. However, a high level of evidence is not necessarily required. Acceptable sources of evidence include at least one well-designed, randomized, controlled trial; well-designed, non-randomized trials; cohort and case control studies; or expert opinion reports.
Finished products licensed by Health Canada must be manufactured according to Good Manufacturing Practices (GMPs) as outlined by Health Canada.
Below is general information about the effectiveness of the known ingredients contained in the product Vaccinium Vitis Idaea. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Vaccinium Vitis Idaea. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
LIKELY SAFE ...when consumed in the amounts commonly found in foods.
POSSIBLY SAFE ...when lingonberry concentrate is used orally and appropriately. A beverage containing cranberry concentrate 7.5 grams and lingonberry concentrate 1.7 grams in 50 mL water has been used with apparent safety for up to 6 months (8253).
POSSIBLY UNSAFE ...when lingonberry leaf extracts are used orally, long-term. Lingonberry leaf contains a constituent that might be hepatotoxic (18). However, a high quality safety assessment of lingonberry leaf in humans has not been conducted. There is insufficient reliable information available about the safety of lingonberry leaf extracts when used orally, short-term.
PREGNANCY AND LACTATION: LIKELY UNSAFE
when used orally because some constituents have mutagenic effects, potentially harming the developing fetus (18); avoid using.
CHILDREN: POSSIBLY SAFE
when lingonberry concentrate is used orally and appropriately.
A beverage containing cranberry concentrate 7.5 grams and lingonberry concentrate 1.7 grams in 50 mL water has been used with apparent safety for up to 6 months (46452).
CHILDREN: POSSIBLY UNSAFE
when lingonberry leaf extracts are used orally, long-term.
Lingonberry leaf contains constituents that might be hepatotoxic (18).
Below is general information about the interactions of the known ingredients contained in the product Vaccinium Vitis Idaea. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Below is general information about the adverse effects of the known ingredients contained in the product Vaccinium Vitis Idaea. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.